Beranda › Tekanan Darah Tinggi › Texas
Uji klinis Tekanan Darah Tinggi di Texas
27 studi untuk Tekanan Darah Tinggi mencari peserta di lokasi di Texas.
Kota di Texas
- Dallas16 studi
- Houston11 studi
- San Antonio7 studi
- Austin6 studi
- The Woodlands5 studi
- Arlington3 studi
- El Paso3 studi
- Fort Worth3 studi
Teks studi resmi (Bahasa Inggris)
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
- Retension Clinical Site, Bellaire
- Retension Clinical Site, Dallas
- Retension Clincal Site, Plano
- dan 2 lainnya
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07142356BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
- Baylor Scott & White Research Institute, Dallas
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06059638A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Horizon Clinical Research Group, Cypress
- Cardiovascular Specialists of Willowbrook, Houston
- Texas Cardiology Associates of Houston, Kingwood
- dan 2 lainnya
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07783802EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Pinnacle Clinical Research - Austin, Austin
- South Texas Research Institute - Brownsville, Brownsville
- Headlands Research - Brownsville, Brownsville
- dan 25 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07064473Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension
- Laguna Clinical Research Associates, Laredo
- Tapia Internal Medicine Clinic, Paris
- Baylor Scott and White Research Institute - Temple, Temple
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07511361A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- IMA Clinical Research Austin, Austin
- Headlands Horizons, LLC dba Headlands Research-Brownsville, Brownsville
- Cedar Health Research - Texas Native Health, Dallas
- dan 10 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07794579A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Research Site, Arlington
- Research Site, Austin
- Research Site, Austin
- dan 8 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06742723THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
- Plaza Medical Center of Fort Worth, Fort Worth
- Houston Medical Center, Houston
Menerima peserta
Usia 22 hingga 75 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06559891Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Allen
- Clinical Trial Site, Amarillo
- Clinical Trial Site, Amarillo
- dan 43 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT07181109Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)
- University of Texas Southwestern Medical Center, Dallas
Menerima pesertaFase awal 1Sukarelawan sehat diterima
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT04838678IMPACT: Improving Maternal Postpartum Access to Care Through Telemedicine
- Parkland Hospital, Dallas
Menerima pesertaSukarelawan sehat diterima
Usia 18 ke atas · Wanita · Diperbarui 2 Sep 2026 · NCT06218355Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- Dell Children's Medical Center of Central Texas, Austin
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 0 hingga 20 · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT04278404Global Paradise System US Post Approval Study
- Ascension Seton, Austin
- Dallas VAMC, Dallas
- TCR Institute, Kingwood
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT06297291Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
- UT Southwestern Medical Center, Dallas
- University of Texas Health Science Center San Antonio, San Antonio
Menerima pesertaStudi observasional
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT06402968Polypill for Prevention of Cardiomyopathy
- UT Southwestern Medical Center, Dallas
Menerima pesertaFase 1/2
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT06143566A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
- Synergy Group Medical LLC, Houston
- Synergy Group Medical LLC, Houston
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 30 Jul 2026 · NCT07610278An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
- Sun Research Institute, San Antonio
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Jul 2026 · NCT07543120A Pivotal Study to Evaluate the Effectiveness of Isometric Handgrip Therapy in Elevated Blood Pressure and Hypertensive Subjects
- Zenos Clinical Research, Dallas
- Aavon Clinical Trials, Houston
Menerima peserta
Usia 22 ke atas · Semua jenis kelamin · Diperbarui 24 Jul 2026 · NCT06843577Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Jul 2026 · NCT04163614SPYRAL GEMINI Pilot Study
- Baylor Heart & Vascular Hospital, Dallas
- UT Health East Texas, Tyler
Menerima peserta
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 24 Jun 2026 · NCT06907147Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
- University of Texas Medical Branch, Galveston
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Mei 2026 · NCT05955339The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans Aged 55+. It Combines Pharmacist Counseling and CHW Support to Improve Blood Pressure Control in Hypertension Management.
- 3100 Cleburne Street, Nabrit Science Building,, Houston
Menerima peserta
Usia 55 ke atas · Semua jenis kelamin · Diperbarui 13 Apr 2026 · NCT07413159PRESSURE CHECK: Find Your Path to Better Health
- Houston Methodist, Houston
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Mar 2026 · NCT06122246Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
- Vanda Investigative Site, Carrollton
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 27 Feb 2026 · NCT07090161Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions
- UT Southwestern Medical Center, Dallas
Menerima peserta
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 10 Feb 2026 · NCT05168605Preventing Cognitive Decline by Reducing BP Target Trial
- UT Southwestern Medical Center, Dallas
Menerima peserta
Usia 70 ke atas · Semua jenis kelamin · Diperbarui 3 Des 2025 · NCT05106036Targeting Endoplasmic Reticulum Stress in Human Hypertension
- University of North Texas Health Science Center, Fort Worth
Menerima pesertaFase 1/2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 28 Mar 2025 · NCT06025630Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.